Publications by authors named "Jeff Schein"

Claim this Profile
H
Healthcare Costs Associated with Adverse Events in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Claims-Based Study.
Jeff Schein, Maryaline Catillon, Anaïs Lemyre, Alice Qu, Frederic Kinkead

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d'un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d'innocuité et d'efficacité à court terme.
Jeff Schein, Maryaline Catillon, Chunyi Xu, Alice Qu, Anaïs Lemyre

Can J Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agitation in individuals with Alzheimer's disease: An assessment of behaviors using the cohen-mansfield agitation inventory in community-dwellers and impact on caregiver experience.
George Grossberg, Cynthia Willey, Christy Houle, Jeff Schein, Rebecca Bungay

Dementia (London)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Louise Yu

J Child Adolesc Psychopharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Yan Meng

Neurol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu

J Comp Eff Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of centanafadine in adults with ADHD: a matching adjusted indirect comparison versus methylphenidate hydrochloride extended release (Concerta).
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu

Curr Med Res Opin· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder - A Discrete Choice Experiment.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Yan Meng

Patient Prefer Adherence· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Kathleen Chen

Child Adolesc Psychiatry Ment Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu

J Manag Care Spec Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Kathleen Chen

J Manag Care Spec Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder.
Jeff Schein, Martin Cloutier, Rebecca Bungay, Marjolaine Gauthier-Loiselle, Ann Childress

J Med Econ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world assessment of healthcare costs associated with agitation in Alzheimer's dementia.
George Grossberg, Annette Urganus, Jeff Schein, Rebecca Bungay, Martin Cloutier

J Med Econ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors associated with newly diagnosed attention-deficit/hyperactivity disorder in adults: a retrospective case-control study.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Emmanuelle Arpin

BMC Psychiatry· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis.
Jeff Schein, Ann Childress, Patrick Gagnon-Sanschagrin, Jessica Maitland, Jerome Bedard

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin

Curr Med Res Opin· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin

Adv Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying individuals with undiagnosed post-traumatic stress disorder in a large United States civilian population - a machine learning approach.
Patrick Gagnon-Sanschagrin, Jeff Schein, Annette Urganus, Elizabeth Serra, Yawen Liang

BMC Psychiatry· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States - a retrospective claims analysis.
Jeff Schein, Ann Childress, Julie Adams, Patrick Gagnon-Sanschagrin, Jessica Maitland

BMC Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Agitation in Dementia on Caregivers: A Real-World Survey.
Jeff Schein, Christy R Houle, Annette L Urganus, Eddie Jones, James Pike

J Alzheimers Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study.
Jeff Schein, Ann Childress, Martin Cloutier, Urvi Desai, Andi Chin

BMC Psychiatry· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.
Lori L Davis, Jeff Schein, Martin Cloutier, Patrick Gagnon-Sanschagrin, Jessica Maitland

J Clin Psychiatry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
Jeff Schein, Lenard A Adler, Ann Childress, Patrick Gagnon-Sanschagrin, Mikhaïl Davidson

J Manag Care Spec Pharm· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
Jeff Schein, Lenard A Adler, Ann Childress, Martin Cloutier, Patrick Gagnon-Sanschagrin

J Med Econ· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study.
Jeff Schein, Ann Childress, Julie Adams, Martin Cloutier, Patrick Gagnon-Sanschagrin

Curr Med Res Opin· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis